Marta Wlodarska, PhD

Odyssey Therapeutics

Poster(s):

• P4328 - RIPK2 Scaffolding Inhibitors are a Novel Approach to Block RIPK2 Signaling, a Hallmark of Inflammatory Bowel Disease
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET